[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.92.62. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1985

Tubulointerstitial Renal Disease in Systemic Lupus Erythematosus

Author Affiliations

From the Divisions of Rheumatology (Drs O'Dell, Hays, and Steigerwald) and Nephrology (Dr Guggenheim) and the Department of Pathology (Dr Guggenheim), University of Colorado Health Sciences Center, and the Denver Veterans Administration Medical Center. Dr O'Dell is now with the University of Nebraska Medical Center, Omaha; Dr Hays is now with the Madigan Army Medical Center, Fort Lewis, Wash; and Dr Guggenheim is now with Montana State University, Bozeman.

Arch Intern Med. 1985;145(11):1996-1999. doi:10.1001/archinte.1985.00360110066018
Abstract

• Tubulointerstitial renal disease is found frequently in patients with systemic lupus erythematosus. Despite the frequency of this entity, little is known about the prognostic significance of this biopsy finding. We reviewed 46 consecutive renal biopsy specimens from patients with systemic lupus erythematosus who were followed up for a mean of 5.4 years. Tubulointerstitial abnormalities were present in 39% of the entire group of patients and in 51% of the patients who had clinical evidence of renal abnormalities. Tubulointerstitial inflammation was closely associated with diffuse proliferative glomerulonephritis, with elevation of serum creatinine (SCr) concentration at biopsy, and with increased frequency of proteinuria both at biopsy and at follow-up. Additionally, active interstitial inflammation was associated with an increased risk of doubling the entry SCr concentration. The presence or absence of tubulointerstitial disease, however, did not add additional prognostic information to the predictive power of the entry SCr concentration or the glomerular histologic features.

(Arch Intern Med 1985;145:1996-1999)

×